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The pituitary gland is also known as the “master gland” of
the body; although minute in size, it has an influence over
every major organ-system. The most common tumor of
the pituitary (and therefore the most common reason for
surgery on this gland) is pituitary adenoma. Pituitary
adenomas are the third most common primary intracranial
tumor after gliomas and meningiomas, representing
approximately 19% of all surgically resected primary brain
t u m o r s .1 Autopsy studies suggest a prevalence of upto
27%. Two types of adenomas have been described;
functioning adenomas are hormonally active, representing
70% of all pituitary tumors; non-functioning adenomas are
less common and do not secrete hormones. Clinical
presentation is either due to endocrine manifestations
(functioning adenomas), or mass effect (non-functioning
adenomas, which are also generally larger). Up to 2% of
pituitary adenomas also present as pituitary apoplexy,
although sub-clinical hemorrhage is evident in 10% of all
pituitary surgical specimens even without a preceding
history of an apoplectic event.2
Hardy et al proposed a classification of pituitary tumors
based on radiological size, including micro- (<10 mm) and
macro-adenomas (>10mm), that are further sub-divided
into five grades depending upon sellar appearance. Tumors
more than 40 mm in maximum dimension are generally
considered 'giant pituitary tumors', an entity considered
unusual in the modern era of better patient awareness,
early presentations, and advanced neuro-imaging.3
Surgical resection has established itself as the cornerstone
of management, and may be carried out through a number
of approaches. Trans-sphenoidal is the commonest, least
traumatic, and regarded as the 'gold standard'.4 , 5 T r a n s -
nasal trans-sphenoidal hypophysectomies are amongst the
safest procedures in neurosurgical practice, with operative
mortality and major morbidity rates of 0.5 to 1% and 2.2
to 3.4% respectively in different series. Lesser morbidity is
been reported in 4-5% of patients, most of whom have
complete recovery.6 , 7 Radiotherapy is only indicated as an
adjunct to surgery, reserved for residual or recurrent
tumors.8,9
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ABSTRACT
Objective: To review the epidemiology and surgical outcomes of patients presenting with pituitary adenomas. Materials
and Methods: Hospital charts were retrieved using the ICD9-Clinical Modifications system, and data recorded on a
structured form. A total of 100 consecutive patients undergoing surgery at our hospital for sellar masses from 1998 to
2004, and with final histopathological diagnosis of pituitary adenoma, were selected. Information was collected on multiple
variables and standard statistical analyses were performed. Results: Of 100 patients, 65 were male and 35 female. Mean
age was 38 _+ 16 years (range 1-76 years). Commonest symptoms were headache and visual disturbance (seen in 60%);
twenty four patients presented with features of acromegaly. Mean duration of symptoms (excluding apoplexy), was 16
months (range 1 month-18 years). Ten patients had pituitary apoplexy. Hormone studies were available for 90 patients;
(46% functioning adenomas, 54% non-functioning; 53% macro-adenomas, 47% micro-adenomas); commonest elevated
hormone was growth hormone. Males were more likely to have macro-adenomas and non-functioning adenomas. Mean
pituitary adenoma size was 26.74 _+ 16 mm (range 3-78 mm). Commonest surgical approach was trans-nasal trans-
sphenoidal (88%). Mean follow-up was 17.34 months (clinical) and 8.79 months (radiological). Post-operative radiotherapy
was administered to 14 patients, nine of whom were re-operated for residual tumor. Conclusion: Surgical management of
pituitary tumors in Pakistan is satisfactory and comparable with the international literature. In contrast with Western series,
our patients are more likely to present either with a giant pituitary adenoma or with apoplexy.
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In this retrospective audit, we have reviewed our surgical
experience with 100 consecutive hypophysectomies
performed during a 6-year time period at a single institute.
To our knowledge, this is the largest  series of
hypophysectomy cases thus far reported from Pakistan. 
MATERIALS AND METHODS 
Medical records at our facility from 1998-2004 were
searched using the ICD-9 Clinical Modifications code for
the term “hypophysectomy.” Information was extracted on
the fol lowing var iab les: demographics,  cl inica l
presentation, biochemical and radiological data, duration
of the operative procedure, length of hospital stay,
complications, and clinical, biochemical and radiological
follow-up. 
All patients had MRI scans before and after the surgery,
the findings of which were available in the file, although
only seventy of the preoperative and sixty four of the
postoperative scans were available in the hospital
radiological records room for comparison at the time of
this study. Post-operative regression in tumor size was
estimated either from the clinical record or by imaging
studies. All patients underwent complete hormonal work-
up before and after surgery (except for the ten cases who
presented with pituitary apoplexy, who had post-operative
hormonal studies only). Tumors were classified as
functioning and non-functioning according to hormonal
status. Complications were also recorded although
transient diabetes insipidus (lasting <72 hours requiring
none or a single dose of intravenous or intranasal
desmopressin), mild self-limiting CSF rhinorrhea and
temporary hormone replacement after surgery (lasting less
than the hospita l s tay)  were not  considered as
complications and overlooked for this purpose. Data was
analyzed using Statistical Package for Social Sciences
SPSS (version 13.0) software; results were expressed as
mean _+ standard deviation and median (with range) for all
continuous variables, and as percentages and proportions
for categorical data.   
RESULTS
During the six-year study period, a total of 100 patients
were operated for histopathologically proven pituitary
adenoma. Of these, 65 were male and 35 female. Sixty
three patients were permanent residents of Karachi, with
the rest coming from other cities of Pakistan and one
individual from Afghanistan. Mean age of patients at the
time of the diagnosis was 38 ± 16 years (range 1-76
years). The mean age of male patients was 39 ± 17 years
and of females was 33 ± 12 years. A majority (43%) of
patients were in their 3r d and 4t h decades of life. A
relatively high frequency (20%) was noted in the 0-20
year age group. 
The most commonly reported symptom was headache or
visual disturbance or both, seen in 60% of patients,
including the 10 patients with pituitary apoplexy (<10
days duration of symptoms). Twenty four pat ients
presented with features of acromegaly. Mean duration of
symptoms (excluding those who presented with apoplexy)
was 16 months (range 1 month-18 years). 
Of the 90 patients without apoplexy, 46% had functioning
and 54% had non-functioning adenomas. The number of
patients who had macro-adenomas was 48, with 42
having micro-adenomas. The remaining ten patients had
pituitary apoplexy and eight of these patients were male.
Of 57 male patients who had pre-operative hormone
levels available, 21 (37%) had functioning and 36 (63%)
had non-functioning adenomas. Functioning adenomas in
females were 20 out of a total of 33 (60%). The
remaining 13 (40%) female patients had non-functioning
adenomas. Male patients were thus found more likely to
present with non-functioning adenomas as compared to
female patients, who were more likely to present with
functioning adenomas. Male patients were also found
more likely to present with macro-adenomas (35 of 55)
and female patients with micro-adenomas (22 of 35). The
most commonly raised hormone was growth hormone in
25 patients (24 with apparent features of acromegaly),
followed by cortisol in 15 patients and prolactin in 12
patients. 
Of the seventy  pre-operat ive MRI scans that were
available, the mean size of pituitary adenomas was 26.74
± 16 mm (range 3-78 mm). Sixteen (21%) tumors
exceeded 40 mm in size (so-called giant pituitary tumors).
Sixteen cases were classified as microadenomas (<10
mm). The main surgical approach was trans-nasal trans-
sphenoidal, performed in 88 cases. In 9 cases the
approach was trans-labial trans-sphenoidal, and 3
patients underwent craniotomy. Mean operative time was
120 ± 62 minutes (range 45-500 minutes). Mean length
of hospital stay was 8 ± 8 days (range 2-73 days). Final
histopathology revealed pituitary adenoma in all patients,
with suggestion of apoplexy in 10 patients.
Mean clinical follow-up was 17.34 ± 20 months (range
1-96 months). Radiological follow-up of 8.79 ± 11.97
months (range 0-48 months) was available in 64 cases.
Mean postoperative size of adenomas in this subgroup
was 5.30 ± 6.1 mm (range 0-31 mm), with complete
resection (0-5% residual tumor) achieved in 40 (63%) of
the cases. Overall, more than 50% resection was
achieved in 55 (86%) of these 64 patients. Post-operative
hormonal supplementation was required in 30 of the 100
patients, with only 15 requiring hormone supplementation
beyond 3 months. Post-operative radiotherapy was
administered to 14 patients, of which 9 were re-operated
for residual tumor.
Mortality was limited to 1 individual, a 9-month old child
wi th a macro-adenoma for  which craniotomy was
underway, and who died of excessive intra-operative blood
loss. Other major complications included CSF rhinorrhea
in 4 and meningitis in 2 patients. Minor morbidities
included diabetes insipidus in 10 and other hospital-
acquired infections (such as urinary tract infection) in 6
cases.
DISCUSSION
This is a relatively modest series of hypophysectomies
when compared with the published international data. A
possible reason may be the small number of pituitary
surger ies in  Pak istan; to our knowledge this is,
nevertheless, the largest series of hypophysectomies
repor ted f rom Pak is tan. On average 14 to 18
hypophysectomies are performed every year at our
institution, although the trend shows a consistent annual
increase. The current study provides comprehensive
information on demographics and tumor behavior in
patients with pituitary adenomas in our population. It may
be argued that the series is based on the results of a
single institute and may not be widely representative, we
believe it may reflect to some extent the true spectrum of
surgically treated pituitary tumors in Pakistan. In contrast
to several other series, in our study female patients were
outnumbered by male patients. This pattern has been
noticed in reports from this part of the world, where males
may be more likely to seek medical care.10,11 However, as
with other series of pituitary adenomas, the mean age of
female patients was less than that of males. 
Age distribution in our study is very similar to what has
been reported in the literature from other centers.12,13 We
found a large number of patients presenting in the fourth
and fifth decades of life, in accordance with what has
been reported in literature. There was also a relatively
increased frequency of patients less than 20 years of age.
This is in contrast to the fact that pituitary adenomas
represent only 2-5% of all primary brain tumors in
children14,15 as compared to 15-19% in adults.1
Worldwide, the most common presentation of pituitary
adenomas is endocrinological abnormalities and their
m a n i f e s t a t i o n s .1 0 However, in our  series, a larger
proportion of patients presented with symptoms of
headache, visual disturbances, or both. Another important
finding was the strikingly high number of patients who
presented with apoplexy. Internationally reported data
suggest that only 1-2% of patients with pituitary adenoma
present with apoplexy.2 Interestingly, 80% of patients
presenting with apoplexy were male. Another difference
between male and female patients was noted when
comparing micro- and macro-adenomas. Male patients
were more likely to present with a macro-adenoma when
compared with female patients. An observation of
relatively less significance is the greater frequency of
functional adenomas in females. 
Overa ll ,  we  found more macro-adenomas than
microadenomas. Our series also shows that a significant
proportion (21%) had giant pituitary adenomas, although
the reported frequency of giant pituitary tumors is not
more than 6% of all cases of pituitary adenomas.1 6 A n
epidemiologic basis of this high frequency may be
suggested on the basis of similar statistics (13.7%) in a
series reported from Mumbai recently.9
Apart from the possibility that pituitary tumors in this
part of the world are biologically distinct, there are other
possible explanations. There may be reluctance to seek
medical care due to pover ty, especially  for those
symptoms which are not immediately alarming and do
not interfere with a daily wagers work (for e.g., headache
and fatigue as compared to sudden loss of vision). It
may also be due to low population literacy and huge
popularity of various forms of alternative medicine and
quacks where the patients might just be provided with
symptomat ic  care wi thout a thorough cl in ica l
examination and investigations for a more sinister
underlying diagnosis. A third reason may be the non-
availability of specialized healthcare in remote areas and
absence of a proper referral system in areas where
healthcare is available. Hence patients in our population
may be more likely to present with pituitary apoplexy and
g iant p ituitary tumors than patients in developed
c o u n t r i e s .
In our center, more patients had functionally inactive
tumors than functioning active ones, although the
international literature reports that a majority of tumors
are functionally active at diagnosis, with a reported
propor tion of seventy  percent .1 7 Our find ing of a
relatively high frequency of non-functioning pituitary
adenomas could perhaps be explained by the smaller
number of female patients in our study, as females are
more l ike ly  to present  wi th endocrinopath ies.
Additionally, patients in our population are less likely to
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undergo a thorough hormonal workup because of a lack
of laboratories offering this facility. It is also worth noting
that in contrast to the published literature prolactinomas
in our study were not the most commonly encountered
funct ioning adenomas.1 7 The major ity o f macro-
adenomas in our series were non-functioning while most
micro-adenomas were functionally active, a pattern that
has also been reported in the literature.
Trans-sphenoida l surgery is the major route for
hypophysectomy used in our institution, as has been
advocated in the literature.4 , 5 In 40 of the 64 patients
whose post operative MRI scans were available, the tumor
resection was complete, with more than 50% resection of
the tumor and remission of symptoms achieved in 55 of
these 64 patients. An operative mortality of one percent
for transsphenoidal hypophysectomy at out institution is
less than what has been reported over the years.6,7 The
incidence of major and minor morbidities in our study
population is comparable to what has been reported from
the rest of the world as well. CSF rhinorrhea occurred in
four patients (reported incidence 3.9%), meningitis in 2
patients (reported incidence 2-6%), 10 patients had
diabetes insipidus (reported incidence 17-18%), and 6
patients had other infections such as urinary tract
infections (reported incidence up to 10%). Proportion of
patients requiring hormone replacement beyond three
months was 15%, which is far more than the reported
incidence of 3-5% of iatrogenic hypopituitarism. 
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